Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

NCT00189787 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00189787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
Not reported
Completion date
August 31, 2005
Enrollment
370 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, bronchial, bronchial asthma